raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:98831

Acute myeloid leukemia with 11q23 abnormalities

Synonyms: AML with 11q23 abnormalities

Type
Disease
Group
Disorder
Age of onset
Childhood
Status
active

A rare tumor arising from hematopoietic and lymphoid tissues characterized by abnormal proliferation and differentiation of a clonal population of myeloid stem cells carrying unspecific 11q23 abnormalities. Clinical manifestations result from accumulation of malignant myeloid cells within the bone marrow, peripheral blood and other organs, and include leukocytosis, anemia, thrombocytopenia, fatigue, anorexia and weight loss.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcute myeloid leukemia with 11q23 abnormalitiesAML with 11q23 abnormalities
frLeucémie aiguë myéloïde associée à des anomalies en 11q23
deAML mit 11q23-Anomalien
esLeucemia mieloide aguda por anomalías en 11q23LMA con anomalías 11q23
itLeucemia mieloide acuta con anomalie di 11q23AML con anomalie 11q23
nlAcute myeloïde leukemie met 11q23-anomalieënAML met 11q23-anomalieën
ptLeucemia mielóide, aguda, com anomalias 11q23
plOstra białaczka szpikowa z nieprawidłowościami 11q23AML z nieprawidłowościami 11q23
csAkutní myeloidní leukémie s abnormalitami 11q23AMS s abnormalitami 11q23
ukГостра мієлоїдна лейкемія з аномаліями 11q23ГМЛ з аномаліями 11q23
zh急性髓系白血病伴11q23异常AML伴11q23异常
tr11q23 anormallikleri ile seyreden akut miyeloid lösemi11q23 anormallikleri ile seyreden AML

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C92.6Especificvalidated
ICD-112A60.0NTBTindexvalidated
ICD-11XH1E41Especificvalidated
MONDO0020317Evalidated
UMLSC1292775Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
KMT2ARole in the phenotype ofAssessedHGNC:7132ENSG0000011805815955511q23.3lysine methyltransferase 2A
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence<1 / 1 000 000—EuropeClass onlyValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card